Telescope Innovations (TELI) Q4 2025 earnings summary

Executive summary

• Achieved revenue growth to $5.8M for FY 2025, up from $4.4M in FY 2024, driven by commercial projects and product launches.

• Transitioned from development to commercialization, highlighted by record sales and new industry collaborations.

Financial highlights

• Revenues reached $5.8M, a 32% increase year-over-year from $4.4M in FY 2024.

• Expenses rose to $7.3M from $5.8M in FY 2024.

• Adjusted EBITDA loss widened to $402K from $152K loss in FY 2024.

Outlook and guidance

• Anticipates continued demand for intelligent, automated chemistry and manufacturing insights.

• Ongoing expansion of SDL deployments in Asia and further commercialization of DirectInject-LC™.